Cryospray Improved Chronic Bronchitis Symptoms
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Read MoreData shows that metered cryospray therapy with the investigational RejuvenAir System leads to airway remodeling and improved symptoms in chronic bronchitis patients.
Read MoreA 12-month feasibility study of the RejuvenAir Metered Cryospray system revealed “clinically meaningful improvements” in COPD patients with chronic bronchitis.
Read MoreCSA Medical Inc has secured $23 million in financing to advance its two novel cryospray therapy platforms, truFreeze and Rejuvenair.
Read MoreA clinical study will evaluate the safety and feasibility of treating chronic bronchitis patients with the RejuvenAir System, a “cryotherapy” spray that freezes and ablates unwanted tissue inside the lungs.
Read More